Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP923079.RAUoCR8Tuc6SWJRNn6SzhlwpEo3KoLbfga0CUFkhnHldM130_assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923079.RAUoCR8Tuc6SWJRNn6SzhlwpEo3KoLbfga0CUFkhnHldM130_provenance.
• NP524444.RAxV-hQqPz996pv9cCp6MERh87SVa3_zuli9j-qJLuIyg130_assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524444.RAxV-hQqPz996pv9cCp6MERh87SVa3_zuli9j-qJLuIyg130_provenance.
• NP551205.RAjCh7JEaGmXgffO6GmqSuism0l_585TTRqzNKT8suOmU130_assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP551205.RAjCh7JEaGmXgffO6GmqSuism0l_585TTRqzNKT8suOmU130_provenance.
• assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP839773.RAWkKOTdG5Xy2Ui_aAWgqqbGmU1mmlJJSDmKelOl4Oa7U130_assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP839773.RAWkKOTdG5Xy2Ui_aAWgqqbGmU1mmlJJSDmKelOl4Oa7U130_provenance.
• NP839776.RAXjNqYzTbHwri81iG0aknJPYR38nmnFriOSvn1BxRpFo130_assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP839776.RAXjNqYzTbHwri81iG0aknJPYR38nmnFriOSvn1BxRpFo130_provenance.
• assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1347570.RAffiJhjRkEcwJyY7m04rwnALxbXCplGt-3fa-usCdnUI130_assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1347570.RAffiJhjRkEcwJyY7m04rwnALxbXCplGt-3fa-usCdnUI130_provenance.
• NP1347571.RAXgt-MWKVZTMyrBn7SfUT_P8ZanrsxUGKYbEf6hjsP6E130_assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1347571.RAXgt-MWKVZTMyrBn7SfUT_P8ZanrsxUGKYbEf6hjsP6E130_provenance.
• NP1347572.RAWU63VGXDp2WVgAhynV1JGEh6PjSh6dv3bkpcmJFaIrg130_assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1347572.RAWU63VGXDp2WVgAhynV1JGEh6PjSh6dv3bkpcmJFaIrg130_provenance.
• NP318375.RAuecCc5H_Ndf99tpVmDh0Cx7RhJ5mfv-WC9hjwKE0oxw130_assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP318375.RAuecCc5H_Ndf99tpVmDh0Cx7RhJ5mfv-WC9hjwKE0oxw130_provenance.
• NP839782.RABNFxvJPijQ2s6hVZFNeWoaC7GGCAdq3lazjWypnv77s130_assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP839782.RABNFxvJPijQ2s6hVZFNeWoaC7GGCAdq3lazjWypnv77s130_provenance.
• NP1347573.RAr80FSOsi-1EJ7hNH1P7DTIsPkMvTvnSCHcc6tXLCK2Y130_assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1347573.RAr80FSOsi-1EJ7hNH1P7DTIsPkMvTvnSCHcc6tXLCK2Y130_provenance.
• NP1347574.RAuFVzwn2njt1FOpQG-k5RA1D4E5kjO4MDTzQkGUJRkiQ130_assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1347574.RAuFVzwn2njt1FOpQG-k5RA1D4E5kjO4MDTzQkGUJRkiQ130_provenance.
• NP1347577.RAkwWNua1Zehn93r3XW2SKmEw4ihYv2Qpo6K8jzza0fG0130_assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1347577.RAkwWNua1Zehn93r3XW2SKmEw4ihYv2Qpo6K8jzza0fG0130_provenance.
• NP318379.RA86IL0XQN4mFBWYN5sJZQDtpu62SDuzMsXGm9M-8STnQ130_assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP318379.RA86IL0XQN4mFBWYN5sJZQDtpu62SDuzMsXGm9M-8STnQ130_provenance.
• NP318386.RAMYJBDLLtph8D8y4-8n2e9lIsoOzc8x7I6EHgdPzcdFY130_assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP318386.RAMYJBDLLtph8D8y4-8n2e9lIsoOzc8x7I6EHgdPzcdFY130_provenance.